NASDAQ : VIVO
VivoPower PLC — Key statistics
Healthcare · Pharmaceuticals · United Kingdom
Last price 2.6 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 83.18M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 70.55M |
| Enterprise Value | 99.67M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 23, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 31.99M |
| Shares Outstanding | 31.99M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 16.07% |
| Owned by Institutions (%) | 9.96% |
| Float | 18.46M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,243.03 |
| Forward PS | n/a |
| PB Ratio | 2.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1,720.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.34 |
| Quick Ratio | 1.30 |
| Debt / Equity | 1.89 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.45 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -12.25% |
| Return on Invested Capital (ROIC) | -45.27% |
| Return on Capital Employed (ROCE) | -34.70% |
| Weighted Average Cost of Capital (WACC) | 4.04% |
| Revenue Per Employee | $1,488 |
| Profits Per Employee | -$426,610 |
| Employee Count | 41 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.04 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.14M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.68 |
| 52-Week Price Change | -22.20% |
| 50-Day Moving Average | 3.36 |
| 200-Day Moving Average | 3.45 |
| Relative Strength Index (RSI) | 36.47 |
| Average Volume (20 Days) | 952,652 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.14M |
| Short Previous Month | 2.14M |
| Short % of Shares Out | 6.69% |
| Short % of Float | 11.59% |
| Short Ratio (days to cover) | 4.72 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 61,000 |
| Gross Profit | 11,000 |
| Operating Income | -12.00M |
| Pretax Income | -18.00M |
| Net Income | -17.49M |
| EBITDA | -11.55M |
| EBIT | -12.00M |
| Loss Per Share | -$1.97 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 60,000 |
| Total Debt | 29.19M |
| Net Cash | -29.13M |
| Net Cash Per Share | -$0.91 |
| Equity (Book Value) | 15.41M |
| Book Value Per Share | 0.93 |
| Working Capital | 18.40M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -8.48M |
| Capital Expenditures | -1.27M |
| Depreciation & Amortization | 157,000 |
| Net Borrowing | -135,000 |
| Free Cash Flow | -9.75M |
| FCF Per Share | -$0.30 |
Margins
| Measure | Value |
|---|
| Gross Margin | 18.03% |
| Operating Margin | -19,675.41% |
| Pretax Margin | -29,503.28% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -188.31% |
| Shareholder Yield | -188.31% |
| Earnings Yield | -89.36% |
| FCF Yield | -12.85% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 1,033.01% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 6, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |